SOPHiA GENETICS SA Statistics
Share Statistics
SOPHiA GENETICS SA has 65.38M shares outstanding. The number of shares has increased by 0.37% in one year.
Shares Outstanding | 65.38M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | n/a |
Shares Floating | 46.41M |
Failed to Deliver (FTD) Shares | 669 |
FTD / Avg. Volume | 2.67% |
Short Selling Information
The latest short interest is 24.07K, so 0.04% of the outstanding shares have been sold short.
Short Interest | 24.07K |
Short % of Shares Out | 0.04% |
Short % of Float | 0.05% |
Short Ratio (days to cover) | 1.02 |
Valuation Ratios
The PE ratio is -3.86 and the forward PE ratio is -4.63.
PE Ratio | -3.86 |
Forward PE | -4.63 |
PS Ratio | 4.89 |
Forward PS | 2.7 |
PB Ratio | 2.01 |
P/FCF Ratio | -5.28 |
PEG Ratio | n/a |
Enterprise Valuation
SOPHiA GENETICS SA has an Enterprise Value (EV) of 200.33M.
EV / Earnings | -2.54 |
EV / Sales | 3.21 |
EV / EBITDA | -2.83 |
EV / EBIT | -2.68 |
EV / FCF | -3.47 |
Financial Position
The company has a current ratio of 4.16, with a Debt / Equity ratio of 0.
Current Ratio | 4.16 |
Quick Ratio | 3.97 |
Debt / Equity | 0 |
Total Debt / Capitalization | 0 |
Cash Flow / Debt | 0 |
Interest Coverage | -127.26 |
Financial Efficiency
Return on equity (ROE) is -0.52% and return on capital (ROIC) is -44.28%.
Return on Equity (ROE) | -0.52% |
Return on Assets (ROA) | -0.38% |
Return on Capital (ROIC) | -44.28% |
Revenue Per Employee | 145.05K |
Profits Per Employee | -183.68K |
Employee Count | 430 |
Asset Turnover | 0.3 |
Inventory Turnover | 3 |
Taxes
Income Tax | 486.00K |
Effective Tax Rate | -0.01 |
Stock Price Statistics
The stock price has increased by -25.34% in the last 52 weeks. The beta is 1.03, so SOPHiA GENETICS SA's price volatility has been higher than the market average.
Beta | 1.03 |
52-Week Price Change | -25.34% |
50-Day Moving Average | 3.44 |
200-Day Moving Average | 4.23 |
Relative Strength Index (RSI) | 44.77 |
Average Volume (20 Days) | 25.07K |
Income Statement
In the last 12 months, SOPHiA GENETICS SA had revenue of $62.37M and earned -$78.98M in profits. Earnings per share was $-1.22.
Revenue | 62.37M |
Gross Profit | 42.91M |
Operating Income | -74.83M |
Net Income | -78.98M |
EBITDA | -70.70M |
EBIT | -74.83M |
Earnings Per Share (EPS) | -1.22 |
Balance Sheet
The company has $123.25M in cash and $18.60M in debt, giving a net cash position of $104.65M.
Cash & Cash Equivalents | 123.25M |
Total Debt | 18.60M |
Net Cash | 104.65M |
Retained Earnings | -377.78M |
Total Assets | 177.61M |
Working Capital | 86.34M |
Cash Flow
In the last 12 months, operating cash flow was -$48.58M and capital expenditures -$9.23M, giving a free cash flow of -$57.80M.
Operating Cash Flow | -48.58M |
Capital Expenditures | -9.23M |
Free Cash Flow | -57.80M |
FCF Per Share | -0.89 |
Margins
Gross margin is 68.8%, with operating and profit margins of -119.97% and -126.63%.
Gross Margin | 68.8% |
Operating Margin | -119.97% |
Pretax Margin | -125.85% |
Profit Margin | -126.63% |
EBITDA Margin | -113.35% |
EBIT Margin | -119.97% |
FCF Margin | -92.67% |
Dividends & Yields
SOPH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -37.31% |
FCF Yield | -27.08% |
Analyst Forecast
The average price target for SOPH is $7, which is 114.1% higher than the current price. The consensus rating is "Buy".
Price Target | $7 |
Price Target Difference | 114.1% |
Analyst Consensus | Buy |
Analyst Count | 3 |
Scores
Altman Z-Score | -1.75 |
Piotroski F-Score | 2 |